Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Sierra Oncology, Inc. (SRRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Rock Springs Capital Management LP reports a 0% stake in Sierra Oncology, Inc. |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/05/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 0% stake in Sierra Oncology, Inc. |
| 03/29/2022 |
SC 13G/A
| Frazier Life Sciences Public Fund, L.P. reports a 10% stake in Sierra Oncology, Inc. |
| 02/14/2022 |
SC 13G/A
| Rock Springs Capital Management LP reports a 7.9% stake in Sierra Oncology, Inc. |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 6.1% stake in Sierra Oncology, Inc. |
| 02/14/2022 |
SC 13G/A
| CAXTON CORP reports a 7% stake in Sierra Oncology, Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 14.7% stake in Sierra Oncology, Inc. |
| 02/11/2022 |
SC 13G/A
| New Leaf Biopharma Opportunities I, L.P. reports a 4.1% stake in Sierra Oncology, Inc. |
| 02/10/2022 |
SC 13G/A
| GILEAD SCIENCES, INC. reports a 9.2% stake in Sierra Oncology, Inc. |
| 02/10/2022 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 8.2% stake in Sierra Oncology, Inc. |
| 01/28/2022 |
SC 13G/A
| Frazier Life Sciences VIII, L.P. reports a 8.4% stake in Sierra Oncology, Inc. |
| 11/05/2021 |
SC 13G/A
| Vivo Capital IX, LLC reports a 14.8% stake in Sierra Oncology, Inc. |
| 02/16/2021 |
SC 13G/A
| CAXTON CORP reports a 9.9% stake in Sierra Oncology, Inc. |
| 02/16/2021 |
SC 13G/A
| Rock Springs Capital Management LP reports a 5.1% stake in Sierra Oncology, Inc. |
| 02/16/2021 |
SC 13G/A
| Mangrove Partners Master Fund, Ltd. reports a 4.8% stake in SIERRA ONCOLOGY, INC. |
| 02/16/2021 |
SC 13G/A
| Mangrove Partners Master Fund, Ltd. reports a 5.1% stake in SIERRA ONCOLOGY, INC. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Vivo Capital IX, LLC reports a 14% stake in Sierra Oncology, Inc. |
| 02/12/2020 |
SC 13G/A
| New Leaf Biopharma Opportunities I, L.P. reports a 7.3% stake in Sierra Oncology, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| New Leaf Biopharma Opportunities I, L.P. reports a 6.8% stake in Sierra Oncology, Inc. |
| 02/13/2019 |
SC 13G/A
| Broadfin Capital, LLC reports a 6.6% stake in Sierra Oncology, Inc. |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|